Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 11 studies | 28% ± 14% | |
endothelial cell | 9 studies | 28% ± 14% | |
microglial cell | 6 studies | 24% ± 7% | |
macrophage | 5 studies | 25% ± 9% | |
epithelial cell | 4 studies | 35% ± 12% | |
interneuron | 3 studies | 36% ± 17% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
ciliated cell | 3 studies | 27% ± 7% | |
GABAergic neuron | 3 studies | 36% ± 6% | |
glutamatergic neuron | 3 studies | 44% ± 5% | |
ependymal cell | 3 studies | 31% ± 16% | |
fibroblast | 3 studies | 22% ± 10% | |
oligodendrocyte | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 33% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 5934.29 | 180 / 180 | 100% | 15.77 | 430 / 430 |
esophagus | 100% | 6181.31 | 1445 / 1445 | 99% | 19.47 | 182 / 183 |
pancreas | 100% | 2993.06 | 328 / 328 | 99% | 16.00 | 177 / 178 |
breast | 100% | 6425.78 | 459 / 459 | 99% | 21.31 | 1111 / 1118 |
lung | 100% | 5501.62 | 576 / 578 | 99% | 21.02 | 1149 / 1155 |
brain | 99% | 3442.10 | 2608 / 2642 | 100% | 25.84 | 705 / 705 |
thymus | 100% | 6538.79 | 653 / 653 | 99% | 16.25 | 596 / 605 |
intestine | 100% | 6334.93 | 966 / 966 | 98% | 15.56 | 518 / 527 |
prostate | 100% | 5337.84 | 245 / 245 | 98% | 13.68 | 493 / 502 |
uterus | 100% | 6168.31 | 170 / 170 | 98% | 22.38 | 450 / 459 |
bladder | 100% | 6344.10 | 21 / 21 | 98% | 16.37 | 494 / 504 |
stomach | 100% | 3735.39 | 359 / 359 | 98% | 13.97 | 280 / 286 |
skin | 100% | 8607.43 | 1809 / 1809 | 97% | 20.95 | 458 / 472 |
kidney | 100% | 3921.52 | 89 / 89 | 97% | 18.27 | 870 / 901 |
adrenal gland | 100% | 3751.24 | 258 / 258 | 92% | 11.60 | 211 / 230 |
liver | 88% | 1889.04 | 198 / 226 | 71% | 6.30 | 287 / 406 |
adipose | 100% | 5784.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6792.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4896.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.88 | 1 / 1 |
muscle | 99% | 3364.67 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 3979.15 | 841 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 11.44 | 28 / 29 |
peripheral blood | 96% | 5140.89 | 895 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 11.11 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046293 | Biological process | formaldehyde biosynthetic process |
GO_2000736 | Biological process | regulation of stem cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_2000036 | Biological process | regulation of stem cell population maintenance |
GO_0006338 | Biological process | chromatin remodeling |
GO_0007290 | Biological process | spermatid nucleus elongation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0032454 | Molecular function | histone H3K9 demethylase activity |
GO_0140683 | Molecular function | histone H3K9me/H3K9me2 demethylase activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KDM3A |
Protein name | Lysine-specific demethylase (EC 1.14.11.65) Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A) Lysine demethylase 3A |
Synonyms | JMJD1A TSGA JMJD1 JHDM2A KIAA0742 |
Description | FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Preferentially demethylates mono- and dimethylated H3 'Lys-9' residue, with a preference for dimethylated residue, while it has weak or no activity on trimethylated H3 'Lys-9'. Demethylation of Lys residue generates formaldehyde and succinate. Involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes, resulting in H3 'Lys-9' demethylation and transcriptional activation. Involved in spermatogenesis by regulating expression of target genes such as PRM1 and TNP1 which are required for packaging and condensation of sperm chromatin. Involved in obesity resistance through regulation of metabolic genes such as PPARA and UCP1. . FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. . |
Accessions | F8WE62 ENST00000427678.1 C9J7Q7 ENST00000312912.10 ENST00000409064.5 ENST00000452034.5 Q9Y4C1 ENST00000441719.5 C9JC73 ENST00000409556.5 |